ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
257.92
+1.50 (0.58%)
Jul 18, 2025, 4:00 PM - Market closed

Company Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.

The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.

The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal.

It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN’s software solutions.

The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force.

ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

ResMed Inc.
ResMed logo
CountryUnited States
Founded1989
IPO DateJun 2, 1995
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees9,980
CEOMichael Farrell

Contact Details

Address:
9001 Spectrum Center Boulevard
San Diego, California 92123
United States
Phone858-836-5000
Websiteresmed.co.in

Stock Details

Ticker SymbolRMD
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJuly - June
Reporting CurrencyUSD
CIK Code0000943819
CUSIP Number761152107
ISIN NumberUS7611521078
Employer ID98-0152841
SIC Code3841

Key Executives

NamePosition
Michael J. Farrell BE, MBA, SMChief Executive Officer and Chairman
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus and Director
Brett A. SandercockChief Financial Officer
Michael J. RiderChief Legal Officer and Secretary
Justin LeongChief Product Officer
Kaushik GhoshalChief Commercial Officer - SaaS
Alastair RobertsonChief Information Officer
Sallilyn SchwartzChief Investor Relations Officer
Jim EllisChief Compliance Officer
Yvonne-Katrin PucknatChief Marketing Officer

Latest SEC Filings

DateTypeTitle
Jul 7, 2025144Filing
Jul 2, 2025144Filing
Jul 1, 2025144Filing
Jul 1, 2025144Filing
Jun 9, 2025144Filing
Jun 4, 2025144Filing
Jun 2, 2025144Filing
Jun 2, 2025144Filing
May 29, 2025SDForm - SD
May 22, 2025144Filing